{
    "eid": "2-s2.0-85034843220",
    "title": "Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer",
    "cover-date": "2018-05-05",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biochemistry",
            "@code": "1303",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Molecular Biology",
            "@code": "1312",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Endocrinology",
            "@code": "1310",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Breast cancer",
        "Estrogen receptor",
        "Growth factor signaling",
        "Nongenomic signaling",
        "Progesterone receptor",
        "Rapid membrane signaling"
    ],
    "authors": [
        "Viroj Boonyaratanakornkit",
        "Nalo Hamilton",
        "Diana C. M\u00e1rquez-Garb\u00e1n",
        "Prangwan Pateetin",
        "Eileen M. McGowan",
        "Richard J. Pietras"
    ],
    "citedby-count": 31,
    "ref-count": 322,
    "ref-list": [
        "The AF-1 activation function of estrogen receptor alpha is necessary and sufficient for uterine epithelial cell proliferation in vivo",
        "Does palmitoylation target estrogen receptors to plasma membrane caveolae?",
        "S-palmitoylation modulates human estrogen receptor-alpha functions",
        "Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol",
        "Mutation of the palmitoylation site of estrogen receptor alpha in vivo reveals tissue-specific roles for membrane versus nuclear actions",
        "Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule",
        "Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity",
        "Prospective identification of tumorigenic breast cancer cells",
        "G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells",
        "Problems and solutions in the evaluation of hormone receptors in breast cancer",
        "Antidiabetic actions of an estrogen receptor beta selective agonist",
        "The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis",
        "HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study",
        "Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance",
        "Estrogen receptor beta and breast cancer",
        "Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells",
        "Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells",
        "Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial",
        "Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo",
        "On the treatment of inoperable cases of carcinoma of the mamma:suggestions for a new method of treatment, with illustrative cases",
        "Blockade of estrogen receptor signaling inhibits growth and migration of medulloblastoma",
        "Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu",
        "Breast cancer and hormone-replacement therapy in the million women study",
        "Activity of megestrol acetate in postmenopausal women with advanced breast cancer after nonsteroidal aromatase inhibitor failure: a phase II trial",
        "Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes",
        "Scaffolding proteins mediating membrane-initiated extra-nuclear actions of estrogen receptor",
        "Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones",
        "Receptor mechanisms mediating non-genomic actions of sex steroids",
        "Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases",
        "The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression",
        "Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen",
        "Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signaling to PI3K/AKT",
        "Hormonal control of alveolar development and its implications for breast carcinogenesis",
        "G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients",
        "The biology and mechanism of steroid hormone receptor interaction with the eukaryotic nucleus",
        "Progesterone receptor membrane component 1: an integrative review",
        "The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology",
        "Deciphering the divergent roles of progestogens in breast cancer",
        "Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells",
        "Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae",
        "Estrogen receptor \u03b1 and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae",
        "The AF-1-deficient estrogen receptor ERalpha46 isoform is frequently expressed in human breast tumors",
        "Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-alpha36 (ERalpha36)",
        "ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches",
        "Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells",
        "Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications",
        "Anatomical location and redistribution of G protein-coupled estrogen receptor-1 during the estrus cycle in mouse kidney and specific binding to estrogens but not aldosterone",
        "Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system",
        "Dissoication between steroid receptor expression and cell proliferation in the human breast",
        "A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer",
        "Alternative splicing and the progesterone receptor in breast cancer",
        "Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone",
        "A truncated progesterone receptor (PR-M) localizes to the mitochondrion and controls cellular respiration",
        "Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells",
        "Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1-and estrogen receptor-containing transcription complexes",
        "Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover",
        "A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer",
        "Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity",
        "Gene expression profiles in human non-small and small-cell lung cancers",
        "Triple-negative breast cancer: immune modulation as the new treatment paradigm",
        "Breast cancer, stem/progenitor cells and the estrogen receptor",
        "Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer",
        "Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance",
        "Identification of membrane progestin receptors in human breast cancer cell lines and biopsies and their potential involvement in breast cancer",
        "Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models",
        "Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications",
        "Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors",
        "Rapid extranuclear signaling by the estrogen receptor (ER): MNAR couples ER and Src to the MAP kinase signaling pathway",
        "Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways",
        "bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study",
        "Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status",
        "Progesterone receptor rapid signaling mediates Ser345 phosphorylation and tethering to Sp1 transcription factors",
        "Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells",
        "Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression",
        "Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF",
        "Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis",
        "PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro",
        "Palbociclib and letrozole in advanced breast cancer",
        "Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1",
        "AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor",
        "Triple-negative breast cancer",
        "Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin",
        "Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton",
        "Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase",
        "The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding",
        "Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion",
        "17beta-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib",
        "Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells",
        "Hormone receptors: studies on the interaction of estrogen with the uterus",
        "Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells",
        "Characterization of progesterone receptor A and B expression in human breast cancer",
        "Preferential stimulation of human progesterone receptor B expression by estrogen in T-47D human breast cancer cells",
        "Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis",
        "Nuclear receptors enhance our understanding of transcription regulation",
        "Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A",
        "Progesterone receptor signaling mechanisms",
        "Production and actions of estrogens",
        "The role of membrane ERalpha signaling in bone and other major estrogen responsive tissues",
        "Molecular determinants of context-dependent progesterone receptor action in breast cancer",
        "ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells",
        "A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells",
        "Estrogen receptor-beta and the insulin-like growth factor Axis as potential therapeutic targets for triple-negative breast cancer",
        "Biologic roles of estrogen receptor-beta and insulin-like growth factor-2 in triple-negative breast cancer",
        "Extranuclear steroid receptors: nature and actions",
        "Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action",
        "Estrogen receptor beta in breast cancer\u2013diagnostic and therapeutic implications",
        "Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer",
        "Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women",
        "Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy",
        "Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer",
        "Progesterone receptor activation of extranuclear signaling pathways in regulating p53 expression in vascular endothelial cells",
        "Progesterone receptor-nf\u03bab complex formation is required for progesterone-induced nf\u03bab nuclear translocation and binding onto the p53 promoter",
        "Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions",
        "Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice",
        "Progesterone receptor in non-small cell lung cancer\u2013a potent prognostic factor and possible target for endocrine therapy",
        "Immunotherapeutic target expression on breast tumors can be amplified by hormone receptor antagonism: a novel strategy for enhancing efficacy of targeted immunotherapy",
        "Basic guide to the mechanism of estrogen action",
        "The estrogen receptor: a model for molecular medicine",
        "Receptors reconsidered: a 20-year perspective",
        "The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway",
        "65 and 47 kDa forms of estrogen receptor in human breast cancer: relation with estrogen responsiveness",
        "Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance",
        "Cystathionine \u03b2-synthase and PGRMC1 as CO sensors",
        "Endocrine therapy in the current management of postmenopausal estrogen receptor-positive metastatic breast cancer",
        "Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling",
        "Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B",
        "Estrogen receptors: bioactivities and interactions with cell signaling pathways",
        "Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells",
        "Comparison between steroid binding to membrane progesterone receptor alpha (mPRalpha) and to nuclear progesterone receptor: correlation with physicochemical properties assessed by comparative molecular field analysis and identification of mPRalpha-specific agonists",
        "Minireview: neural signaling of estradiol in the hypothalamus",
        "Differential sensitivity of preoptic-septal neurons to microelectrophoresed estrogen during the estrous cycle",
        "Extranuclear expression of hormone receptors in primary breast cancer",
        "Splice isoform estrogen receptors as integral transmembrane proteins",
        "Functions of MAPR (membrane-associated progesterone receptor) family members as heme/steroid-binding proteins",
        "Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells",
        "What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway",
        "Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression",
        "Effects of steroid hormones on five functional parameters of Tetrahymena: evolutionary conclusions",
        "Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters",
        "Cloning of a novel receptor expressed in rat prostate and ovary",
        "Direct interactions with G alpha i and G betagamma mediate nongenomic signaling by estrogen receptor alpha",
        "Hormone evolution: the key to signalling",
        "2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta",
        "The progesterone receptor gene maps to human chromosome band 11q13, the site of the mammary oncogene int-2",
        "ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas",
        "Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer",
        "Progesterone receptor transcription and non-transcription signaling mechanisms",
        "A Novel Mechanism Underlying Progestin Resistance in Endometrial Cancer: Loss of the Nuclear Localization of Progesterone B Receptor",
        "Extranuclear steroid receptors are essential for steroid hormone actions",
        "Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors, Nature reviews",
        "Estrogen stimulation of cell migration involves multiple signaling pathway interactions",
        "Estrogen receptor-alpha36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells",
        "Progesterone induces focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor complementary DNA",
        "Estrogen receptor-\u03b2 modulation of the ER\u03b1-p53 loop regulating gene expression, proliferation, and apoptosis in breast cancer",
        "Breast cancer stem cells: current advances and clinical implications",
        "Estrogen receptor \u03b2 as a therapeutic target in breast cancer stem cells",
        "Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors",
        "S-palmitoylation modulates estrogen receptor alpha localization and functions",
        "Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells",
        "Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor",
        "Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer",
        "Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function",
        "The role of estrogens in control of energy balance and glucose homeostasis",
        "The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity",
        "Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells",
        "Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor",
        "Current status of estrogen and progesterone receptors in breast cancer",
        "Evaluation of estrogen receptor assays in human breast cancer tissue",
        "Combinatorial control of gene expression by nuclear receptors and coregulators",
        "p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis",
        "The protective effects of estrogen on the cardiovascular system",
        "Membrane estrogen receptor regulation of hypothalamic function",
        "estradiol membrane-initiated signaling and female reproduction",
        "Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor",
        "Studies on estrogen entry into uterine cells and on estradiol-receptor complex attachment to the nucleus\u2013is the entry of estrogen into uterine cells a protein-mediated process?",
        "Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites",
        "The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer",
        "Progesterone receptor modulates ER [agr] action in breast cancer",
        "Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity",
        "Transmembrane helices in \u201cclassical\u201d nuclear reproductive steroid receptors: a perspective",
        "Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis",
        "Reproductive tissue selective actions of progesterone receptors",
        "The role of estrogen receptor-beta in breast cancer",
        "Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity",
        "Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator",
        "Affinity cytochemistry visualizes specific estrogen binding sites on the plasma membrane of breast cancer cells",
        "Antigen retrieval methods and estrogen receptor immunoexpression using 1D5 antibody: a comparative study",
        "Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer",
        "The biology of antihormone failure in breast cancer",
        "Mechanisms of estrogen action",
        "Estrogen receptor-alpha detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry",
        "Antibodies to the estrogen receptor-alpha modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors",
        "A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study",
        "Estrogen modulates metabolic pathway adaptation to available glucose in breast cancer cells",
        "Estrogen-receptor biology: continuing progress and therapeutic implications",
        "Mechanisms of endocrine resistance in breast cancer",
        "Regulation of breast cancer growth by insulin-like growth factors",
        "Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer",
        "G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol",
        "GPR30 does not mediate estrogenic responses in reproductive organs in mice",
        "Receptors reconsidered: a 20-year perspective",
        "ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2",
        "Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding",
        "Estrogen receptor-alpha is associated with the plasma membrane of astrocytes and coupled to the MAP/Src-kinase pathway",
        "Nature of functional estrogen receptors at the plasma membrane",
        "A conserved mechanism for steroid receptor translocation to the plasma membrane",
        "Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin",
        "Developmental phenotype of a membrane only estrogen receptor alpha (MOER) mouse",
        "DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors",
        "Membrane-localized estrogen receptor alpha is required for normal organ development and function",
        "The human estrogen receptor-alpha isoform hERalpha46 antagonizes the proliferative influence of hERalpha66 in MCF7 breast cancer cells",
        "Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer",
        "Membrane Recognition and Effector Sites in Steroid Hormone Action",
        "Biologic basis of sequential and combination therapies for hormone-responsive breast cancer",
        "Membrane-associated estrogen receptor signaling pathways in human cancers",
        "Endometrial cell calcium and oestrogen action",
        "Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells",
        "Estrogen receptors in uterine plasma membrane",
        "Metabolic and proliferative responses to estrogen by hepatocytes selected for plasma membrane binding-sites specific for estradiol-17beta",
        "Specific internalization of estrogen and binding to nuclear matrix in isolated uterine cells",
        "Immunologic inhibition of estrogen binding and action in preputial-gland cells and their subcellular fractions",
        "HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells",
        "Steroid hormone receptors in target cell membranes",
        "Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells",
        "Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties",
        "Estrogen receptor alpha-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERbeta1 and ERbeta5: potential molecular targets for chemoprevention",
        "Activation of rapid oestrogen signalling in aggressive human breast cancers",
        "Comparison of different antibodies for detection of progesterone receptor in breast cancer",
        "GPR30: a G protein-coupled receptor for estrogen",
        "Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid\u2013, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor",
        "Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells",
        "ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions",
        "Heat shock protein 27 is required for sex steroid receptor trafficking to and functioning at the plasma membrane",
        "Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer",
        "A transmembrane intracellular estrogen receptor mediates rapid cell signaling",
        "Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems",
        "Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells",
        "Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer",
        "Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes",
        "A good drug made better: the fulvestrant dose-response story",
        "Activating ESR1 mutations in hormone-resistant metastatic breast cancer",
        "PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding",
        "Leukocyte composition of human breast cancer",
        "Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP",
        "Cloning and expression of a novel, truncated, progesterone receptor",
        "Hormonal regulation of ovalbumin synthesis in the chick oviduct",
        "Rapid steroid hormone actions via membrane receptors",
        "Modeling of cancer stem cell state transitions predicts therapeutic response",
        "Understanding extranuclear (nongenomic) androgen signaling: what a frog oocyte can tell us about human biology",
        "The effects of tamoxifen on the female genital tract",
        "Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients",
        "Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action",
        "Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation",
        "Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway",
        "The fluid mosaic model of the structure of cell membranes",
        "(6-bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (carbhydraz) acts as a GPER agonist in breast cancer cells",
        "p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis",
        "Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer",
        "Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours",
        "Caveolins, liquid-ordered domains, and signal transduction",
        "Membrane-initiated steroid signaling action of estrogen and breast cancer",
        "The role of Shc and insulin-like growth factor I receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane",
        "Estrogen rapid action via protein complex formation involving ERalpha and Src",
        "Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells",
        "Oestrogen receptor beta immunohistochemistry: time to get it right?",
        "Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen",
        "Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors",
        "ER-alpha36: a novel biomarker and potential therapeutic target in breast cancer",
        "Tumor cell-independent estrogen signaling drives disease progression through mobilization of myeloid-derived suppressor cells",
        "Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen",
        "Membrane recognition and effector sites in steroid hormone action",
        "The binding of estradiol in the uterus: a mechanism for depression of rna synthesis",
        "PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif",
        "Competitive binding assay for the g-protein-coupled receptor 30 (GPR30) or g-protein-coupled estrogen receptor (GPER)",
        "Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions",
        "Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption",
        "Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells",
        "Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor alpha subtypes and their evolutionary origins",
        "G. Breast International Group 1-98 Collaborative, A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer",
        "Actin stress fibers \u2013 assembly, dynamics and biological roles",
        "Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells",
        "The N-terminal region of the chicken progesterone receptor specifies target gene activation",
        "ESR1 ligand-binding domain mutations in hormone-resistant breast cancer",
        "Development of a second-generation antiandrogen for treatment of advanced prostate cancer",
        "Hypothesis: activation of rapid signaling by environmental estrogens and epigenetic reprogramming in breast cancer",
        "Membrane progesterone receptors in reproduction and cancer",
        "Significance of ER-Src axis in hormonal therapy resistance",
        "Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3",
        "Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin",
        "Update on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studies",
        "Comparison of the biological effects of tamoxifen and a new antioestrogen (LY 117018) on the immature rat uterus",
        "Molecular mechanisms underlying progesterone-enhanced breast cancer cell migration",
        "BRI1 is a critical component of a plasma-membrane receptor for plant steroids",
        "A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling",
        "Estrogen Receptor \u03b2 as a pharmaceutical target",
        "Rapid actions of xenoestrogens disrupt normal estrogenic signaling",
        "An N-terminally truncated third progesterone receptor protein, PR(C), forms heterodimers with PR(B) but interferes in PR(B)-DNA binding",
        "Na/K-ATPase, endogenous digitalis like compounds and cancer development \u2013 a hypothesis",
        "Steroid hormone receptors and their regulation by phosphorylation",
        "Steroid receptor phosphorylation: a key modulator of multiple receptor functions",
        "New approaches to reverse resistance to hormonal therapy in human breast cancer",
        "Cytoplasmic estrogen receptor in breast cancer",
        "Repurposing antiestrogens for tumor immunotherapy",
        "The human estrogen receptor-\u03b1 is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators",
        "Targeting estrogen receptor beta in a phase 2 study of high-dose estradiol in metastatic triple-negative breast cancer: a Wisconsin Oncology Network Study",
        "Targeting estrogen receptor beta in a phase 2 study of high-dose estradiol in metastatic triple-negative breast cancer: a Wisconsin oncology network study",
        "American Society of Clinical, P. College of American, American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer",
        "Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis",
        "Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer",
        "2D LC/MS analysis of membrane proteins from breast cancer cell lines MCF7 and BT474",
        "Regulation of the actin cytoskeleton in cancer cell migration and invasion",
        "Expression of both estrogen receptor-beta 1 (ER-\u03b21) and its co-regulator steroid receptor RNA activator protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with estrogen receptor-alpha (ER-\u03b1)-Negative early breast cancer (EBC)",
        "Expression of both estrogen receptor-beta 1 (ER-beta1) and its co-regulator steroid receptor RNA activator protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with estrogen receptor-alpha (ER-alpha)-negative early breast cancer (EBC)",
        "Mitochondrial localization of estrogen receptor beta",
        "Members of the Standardization Ad-Hoc Consensus, Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry",
        "Function of estrogen receptor tyrosine 537 in hormone binding, DNA binding, and transactivation",
        "An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer",
        "A positive feedback loop of ER-alpha36/EGFR promotes malignant growth of ER-negative breast cancer cells",
        "Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor \u03b1",
        "Cloning, expression and characterization of a novel membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes",
        "Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes",
        "Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60023932",
            "affilname": "University of Technology Sydney",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023932",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Los Angeles",
            "@id": "60005247",
            "affilname": "David Geffen School of Medicine at UCLA",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005247",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "CDMRP DOD",
        "Hickey Foundation",
        "Rachadaphisek Sompoch Endowment 2016 Fund Chulalongkorn University",
        "Vera Bradley Foundation for Breast Cancer",
        "Tower Cancer Research Foundation",
        "IUSCC",
        "Gateway Foundation"
    ]
}